Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trial evaluating tranexamic acid in thrombocytopenia
ISRCTN73545489Phase 3Completed
- Sponsor
- NHS Blood and Transplant
- Start
- Apr 2015
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in bleeding associated with thrombocytopenia (TAB) comparing Tranexamic acid with Placebo (2 arms). Primary endpoint: Death or WHO grade 2 or higher bleeding within 30 days. Started Apr 2015; status: completed.
02
Drugs
tranexamic acid
03
Conditions
bleeding associated with thrombocytopenia (TAB)
Beyond the preview
Go deeper on ISRCTN73545489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN73545489.